Literature DB >> 20198303

Preventive effects of enzyme-treated rice fiber in a restraint stress-induced irritable bowel syndrome model.

Osamu Kanauchi1, Keiichi Mitsuyama, Yutaka Komiyama, Minoru Yagi, Akira Andoh, Michio Sata.   

Abstract

Irritable bowel syndrome (IBS) is a common health issue that is characterized by abdominal pain, abnormal bowel movements, altered visceral perception, and abnormal metabolism of 5-hydroxy triptamine (serotonin; 5HT). The use of prebiotics or probiotics treatment for IBS has become increasingly important as an adjunct to pharmaceutical options. The aim of this study was to determine the efficacy of enzyme-treated rice fiber (ERF) on an IBS model. We obtained a new prebiotic from defatted rice bran that was developed as an insoluble dietary fiber through amylase and hemicellulase treatment followed by removal of the soluble fraction. Containing approximately 70% hemicellulose, ERF is utilized by lactobacilli and subsequently converted to butyrate using Eubacterium limosum. We employed a restraint stress IBS model which involved the continuous application of stress for 4 h per day for 3 days. Polycarbophil Ca (PC) (500 mg/kg body weight) was used as a positive control and ERF was added to the diet at 4% in diet. During restraint stress, ERF significantly attenuated urgent fecal excretion, colonic mucosal 5HT secretion, and hyperalgesthesia compared with the control. ERF also significantly increased cecal butyrate production as well as total organic acid content. PC was only effective in regard to preventing increases in 5HT levels. Furthermore, there were no significant levels of pro-inflammatory markers CINC-1 and TNF-alpha among the groups. Although more detailed studies are needed, the ERF prebiotic demonstrated potency in attenuating major symptoms of IBS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20198303     DOI: 10.3892/ijmm_00000376

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  6 in total

Review 1.  Stress and visceral pain: from animal models to clinical therapies.

Authors:  Muriel Larauche; Agata Mulak; Yvette Taché
Journal:  Exp Neurol       Date:  2011-05-06       Impact factor: 5.330

2.  Stress-induced visceral analgesia assessed non-invasively in rats is enhanced by prebiotic diet.

Authors:  Muriel Larauche; Agata Mulak; Pu-Qing Yuan; Osamu Kanauchi; Yvette Taché
Journal:  World J Gastroenterol       Date:  2012-01-21       Impact factor: 5.742

3.  The Association between Prebiotic Fiber Supplement Use and Colorectal Cancer Risk and Mortality in the Women's Health Initiative.

Authors:  Meghan B Skiba; Lindsay N Kohler; Tracy E Crane; Elizabeth T Jacobs; Aladdin H Shadyab; Ikuko Kato; Linda Snetselaar; Lihong Qi; Cynthia A Thomson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-08-27       Impact factor: 4.254

4.  Tong-Xie-Yao-Fang Regulates 5-HT Level in Diarrhea Predominant Irritable Bowel Syndrome Through Gut Microbiota Modulation.

Authors:  Junchen Li; Huantian Cui; Yuzi Cai; Jin Lin; Xin Song; Zijun Zhou; Wantao Xiong; Huifang Zhou; Yuhong Bian; Li Wang
Journal:  Front Pharmacol       Date:  2018-09-28       Impact factor: 5.810

5.  Gegen Qinlian decoction enhances immunity and protects intestinal barrier function in colorectal cancer patients via gut microbiota.

Authors:  Yang Li; Zhong-Xin Li; Chen-Yang Xie; Jing Fan; Ji Lv; Xin-Jian Xu; Jian Lv; Wen-Tao Kuai; Yi-Tao Jia
Journal:  World J Gastroenterol       Date:  2020-12-28       Impact factor: 5.742

6.  Cytokine Response after Stimulation with Key Commensal Bacteria Differ in Post-Infectious Irritable Bowel Syndrome (PI-IBS) Patients Compared to Healthy Controls.

Authors:  Johanna Sundin; Ignacio Rangel; Dirk Repsilber; Robert-Jan Brummer
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.